2012
DOI: 10.1371/journal.pone.0044534
|View full text |Cite|
|
Sign up to set email alerts
|

Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome

Abstract: ObjectiveFew outcome data are available about posterior reversible encephalopathy syndrome (PRES). We studied 90-day functional outcomes and their determinants in patients with severe PRES.Design70 patients with severe PRES admitted to 24 ICUs in 2001–2010 were included in a retrospective cohort study. The main outcome measure was a Glasgow Outcome Scale (GOS) of 5 (good recovery) on day 90.Main ResultsConsciousness impairment was the most common clinical sign, occurring in 66 (94%) patients. Clinical seizures… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

17
114
0
9

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 164 publications
(141 citation statements)
references
References 42 publications
17
114
0
9
Order By: Relevance
“…We performed a systematic by posterior reversible encephalopathy syndrome, drug toxicity such as cyclosporine, betalactams and carbapenems, metabolic disorders, infectious causes and cerebral hemorrhages. 39,40 Life-sustaining therapies consisted of MV in 21-72%, noninvasive ventilation (NIV) in 28-40%, use of vasopressors in 47-68% and renal replacement therapy in 22-41%. 13,20,24,25,30,35 Diagnostic strategy Diagnostic strategy is crucial, as the absence of diagnosis is a key prognostic factor, particularly in ARF setting.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…We performed a systematic by posterior reversible encephalopathy syndrome, drug toxicity such as cyclosporine, betalactams and carbapenems, metabolic disorders, infectious causes and cerebral hemorrhages. 39,40 Life-sustaining therapies consisted of MV in 21-72%, noninvasive ventilation (NIV) in 28-40%, use of vasopressors in 47-68% and renal replacement therapy in 22-41%. 13,20,24,25,30,35 Diagnostic strategy Diagnostic strategy is crucial, as the absence of diagnosis is a key prognostic factor, particularly in ARF setting.…”
Section: Introductionmentioning
confidence: 99%
“…[52][53][54] Noninfectious causes of organ failure are usually diagnosed after exclusion of infections. They are mainly represented by cardiac edema, treatment toxicity, 39,40,[54][55][56][57][58][59][60][61][62][63] hemorrhages, GvHD, long-term allo-HSCT complications, 60,64 comorbidity decompensation and relapse. Several post-allograft complications can occur, but they do not all occur at any particular stage of the disease.…”
Section: Introductionmentioning
confidence: 99%
“…In a retrospective study of severe PRES, Legriel et al reported increased prevalence of status epilepticus and unfavorable functional outcome based on Glasgow Outcome Score [9]. Time to control of causative factor was found to be an independent predictor of 90 day functional outcome, highlighting the importance of recognition of clinical presentation and intervention [10,11].…”
Section: Discussionmentioning
confidence: 99%
“…La terminología del cuadro se fue modificando sobre la base del uso creciente de la resonancia magnética, y a la descripción clásica de lesiones típicas y reversibles hoy se agregan manifestaciones atípicas e irreversibles (Tabla 1). [1][2][3][4][5] Las enfermedades autoinmunes representan el 8%-45% de los casos. El lupus eritematoso sistémico (LES) es la principal patología asociada; [1][2][3]6,7 sin embargo, la asociación LES-EPR pediátrica es muy rara.…”
Section: Introductionunclassified
“…[1][2][3][4][5] Las enfermedades autoinmunes representan el 8%-45% de los casos. El lupus eritematoso sistémico (LES) es la principal patología asociada; [1][2][3]6,7 sin embargo, la asociación LES-EPR pediátrica es muy rara. 4,[6][7][8][9] Se describe una niña que presentó una EPR asociada a un LES, con evolución favorable, en la cual múltiples factores podrían haber contribuido a su desarrollo.…”
Section: Introductionunclassified